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OBJECTIVE: To determine the prevalence of systemic hypertension, diabetes mellitus, hypercholesterolemia, and
hypertriglyceridemia in a Brazilian population in relation to body mass index.
METHOD: Retrospective evaluation of 1213 adults (mean age: 45.2 ± 12.8; 80.6% females) divided into groups
according to body mass index [normal (18.5 - 24.4 kg/m2); overweight (25 - 29.9 kg/m2); grade 1 obesity (30 - 34.9 kg/m2);
grade 2 obesity (35 – 39.9 kg/m2), and grade 3 obesity (≥ 40 kg/m2)]. The prevalence of hypertension, diabetes mellitus,
hypercholesterolemia, and hypertriglyceridemia were analyzed in each group. The severity of cardiovascular risk was
determined. High-risk patients were considered those reporting 2 or more of the following factors: systemic hypertension,
HDL ≤ 35 mg/dL, total cholesterol ≥ 240 mg/dL, triglycerides ≥ 200 mg/dL when HDL ≤ 35 mg/dL, and glycemia ≥ 126 mg/
dL. Moderate-risk patients were those reporting 2 or more of the following factors: systemic hypertension, HDL ≤ 45,
triglycerides ≥ 200 mg/dL, and total cholesterol ≥ 200 mg/dL.
RESULTS: The prevalence of systemic hypertension, diabetes mellitus, hypertriglyceridemia, and low HDL-cholesterol
levels increased along with weight, but the prevalence of hypercholesterolemia did not. The odds ratio adjusted for gender
and age, according to grade of obesity compared with patients with normal weight were respectively 5.9, 8.6, and 14.8 for
systemic hypertension, 3.8, 5.8, and 9.2 for diabetes mellitus and 1.2, 1.3, and 2.6 for hypertriglyceridemia. We also verified
that body mass index was positively related to cardiovascular high risk (P < .001)
CONCLUSION: In our population, cardiovascular risk increased along with body mass index.
KEY WORDS: Cardiovascular risk factors. Obesity. Body mass index. Diabetes mellitus. Systemic hypertension.
Cardiovascular diseases are a ma-
jor cause for mortality in our country.1
Quite a number of epidemiological
studies have reported a clear correla-
tion between obesity and cardiovascu-
lar risk factors.2-4 This correlation has
become quite relevant since the preva-
lence of obesity has been increasing
significantly in Brazil.5 Data from the
National Health and Nutrition Survey
(Pesquisa Nacional de Saúde e
Nutrição – PNSN) show that about
40% of Brazilian adult population is
overweight to some degree.6
People who are overweight are pre-
disposed to higher cardiovascular risk,
especially because obesity is closely
associated with other factors, such as
systemic hypertension (SH), glucose
intolerance, diabetes mellitus (DM),
and dyslipidemia.7-10 Other studies
have shown that obesity is an inde-
pendent risk factor for the occurrence
of atherosclerosis.11
Obesity is defined as the excess of
body fat in relation to lean mass. The
body mass index (BMI) is a simple, re-
producible measurement commonly
used to classify adults as overweight
or obese. BMI provides good correla-
tion with body fat index. Many stud-
ies have demonstrated the impact of
BMI in a given population: the higher
a person’s BMI, the higher their cardio-
vascular risk.2-4,7-10,12 In Brazil, how-
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ever, there are few publications to
show the correlation between BMI and
cardiovascular risk factors.13-15
The present study was aimed at in-
vestigating the prevalence of major
cardiovascular risk factors in a Brazil-
ian population and at subdividing that
population into high, moderate, and
low cardiovascular risk categories ac-
cording to obesity level based on BMI
data.
METHOD
The study population was made up
of 1213 individuals who sought assist-
ance at our hospital. Out of those, 292
nonobese patients (BMI < 30 kg/m2)
sought clinical services for a regular
check up; 921 obese patients who
came to the Endocrinology Obesity
Service were seeking treatment for
their overweight conditions. The
records of all patients who were as-
sisted from 1997 through 2001 were
reviewed retrospectively. Only those
with complete data on the variables
used in the present study were in-
cluded. A total of 978 female patients
(80.6%), and 235 male patients
(19.4%) were studied, with a mean av-
erage age of 45.2 ± 12.8 years. The
higher number of female patients in
the study is due to the fact that more
women seek assistance for treating
obesity than do men.
BMI – calculated as body weight
in kilograms divided by height in
square meters – was used to group pa-
tients as being normal weight (18.5 -
24.4 kg/m2), overweight (25 - 29.9 kg/
m2), mildly obese (grade 1: 30 - 34.9
kg/m2), moderately obese (grade 2: 35
– 39.9 kg/m2), and severely obese
(grade 3: ≥ 40 kg/m2), following World
Health Organization criteria (Table
1).16
Data on systemic hypertension,
DM, and lipid metabolic alterations
were accessed for each patient from
medical records. Plasma glucose, total
cholesterol, HDL-C, and triglycerides
were determined by an automated
enzymatic method (Cobas Integra
Plus equipment using commercial kits
from Roche Diagnostic System Inc.,
Texas).
System hypertension was de-
fined—following the Joint National
Committee17—as systolic blood pres-
sure (sBP) ≥ 140 mm Hg, and diastolic
blood pressure (dBP) ≥ 90 mm Hg, or
having a report on the use of hyper-
tension drugs in the patient´s records.
The methodology used to measure
blood pressure was auscultatory. The
Obesity Outpatient Unit at our hospi-
tal uses special blood pressure equip-
ment for obese patients to adjust to the
larger arm circumference.
Diabetes mellitus was defined as
the presence of a fasting glucose level
of ≥ 126 mg/dL, as suggested by the
Expert Committee on the Diagnosis
and Classification of Diabetes
Mellitus,18 or having a report of the use
of insulin or the administration of oral
hypoglycemic drugs in the patient’s
records.
Hypercholesterolemia was consid-
ered to be the presence of a total cho-
lesterol level over 200 mg/dL.
Hypertriglyceridemia was defined as a
triglyceride level greater than 150 mg/
dL, following the criteria as in Sum-
mary of the Third Report of the Na-
tional Cholesterol Education Program
(NCEP, 2001).19
In the present study, in addition to
carrying out an analysis on the preva-
lence of cardiovascular risk factors for
each obesity level, cardiovascular se-
verity risk was also evaluated. In or-
der to do so, the study population was
divided into 3 cardiovascular risk cat-
egories by using criteria as suggested
by Leite et al. in 200220:
A) Moderate risk—2 or more of the
following factors are present: total
cholesterol ≥ 200 mg/dL, HDL £
45 mg/dL, triglycerides ≥ 200 mg/dL,
plasma glycemia ≥ 126 mg/dL, sBP ≥
140 mm Hg, and dBP ≥ 90 mm Hg.
B) High risk—2 or more of the fol-
lowing criteria are present: total cho-
lesterol ≥ 240 mg/dL, HDL ≤ 35 mg/
dL, triglycerides ≥ 200 mg/dL, and
HDL ≤ 35 mg/dL, plasma glycemia ≥
126 mg/dL, sBP ≥ 140 mm Hg and
dBP ≥ 90 mm Hg.
C) Low risk: when patients did not
present any or presented only 1 of the
factors for moderate or high risk.
Statistics analysis was carried out
using the EPI-Info software program.
For the continuous variables, the
analysis was carried out through mean
and mean deviation calculation. For
classification purposes, absolute and
percentile frequencies of variables
were calculated. For comparative
analysis, the chi-square and Student t
tests were used to determine differ-
ences significance between ratios and
means respectively. For the purpose of
comparing mean values among inde-
pendent groups, 1-way analysis of vari-
ance was used. When testing proved
significant, the Bonferroni adjustment
test was used for group comparisons (in
Table 1- Obesity level classification based on body mass index – World Health
Organization’s criteria /1998.




30-34.9 Obesity – Grade 1 (mild)
35-39.9 Obesity – Grade 2 (moderate)
≥40 Obesity – Grade 3 (severe)
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groups of 2). A logistic regression
model was used to assess the correla-
tion between BMI—irrespective of
any other variable—and high cardio-
vascular risk. All tests were carried out
at the 5% significance level.
RESULTS
The population under study was
made up of 1213 individuals, with
80.6% being females. Population
demographics can be found in table 2.
There was a significant difference be-
tween groups in relation to age and
gender. Individuals in the normal-
weight and overweight groups were
made up of older patients, mostly
males.
Major cardiovascular risks based
on BMI can be found in table 3. An
increase in the prevalence of systemic
hypertension, DM, hypertriglyce-
ridemia, and low HDL-cholesterol in
relation to increasing BMI was clear.
No association was found between
hypercholesterolemia or higher LDL-
cholesterol levels and higher BMI.
The risk factors most clearly associ-
ated with being overweight or obese
were systemic hypertension and DM.
The risk for an overweight or
obese individual for developing sys-
temic hypertension, DM, hypertri-
glyceridemia, and hypercholestero-
lemia for each grade of BMI when
compared to normal weight individu-
als can be found in table 4. An analy-
sis was carried out after age and gen-
der adjustment as a result of group dif-
ferences. Systemic hypertension and
DM risks were significantly higher in
individuals whose BMI was greater
than 30 kg/m2. Individuals who are se-
Table 2 - Population demographics based on body mass index.
Body Mass Index (kg/m2)
Characteristics 18.5 - 24.9 25 - 29.9 30 - 34.9 35 - 39.9 ≥ 40 P
n = 111 n = 181 n = 296 n = 265 n = 360
Gender F / M (%) 66.7 / 33.3 64.1 / 35.9 83.1/16.9 85.7 / 14.3 87.5 / 12.5 < 0.001*
Age (years) 48.9 ± 10.2 50.7 ± 9.5 43.8 ± 13.2 44.0 ± 13.3 43.4 ± 13.4 < 0.05*
Body Mass Index (kg/m2) 22.4 ± 1.6 27.6 ± 1.4 32.7 ± 1.5 37.4± 1.5 47.5 ± 7.6 < .001**
Abdominal circumference (cm) 80.4 ± 7.1 92.9 ± 7.5 99.5 ± 7.1 108.2 ± 7.7 125.2 ± 14.2 < .001**
 * Bonferroni’s test: normal and overweight show no difference. Mild, moderate, and severe obesity have no difference between them. The
difference can be found between normal and overweight versus obesity groups. ** Bonferroni’s test: all groups differ when compared to one
another
Table 4 - Comorbidity risk based on body mass index adjusted for gender and age.
Risk Factor Body Mass Index (kg/m2)
18.5 -24.9 25 - 29.9 30 - 34.9 35 - 39.9 > 40
OR (CI 95%) OR (CI 95%) OR (CI 95%) OR (CI 95%) OR (CI 95%)
Systemic hypertension 1 1.3 (0.7 - 2.4) 5.9 (3.3 - 10.3) 8.6 (4.9 - 15.4) 14.8 (8.3 - 26.2)
DM 1 2.5 (0.9 - 6.9) 3.8 (1.4 - 10.1) 5.8 (2.2 - 15.3) 9.2 (3.6 - 23.7)
Hypercholesterolemia 1 1.1 (0.7 - 1.8). 1.3 (0.9 - 2.1) 1.1 (0.7 - 1.7) 1.0 (0.7 - 1.6)
Hypertriglyceridemia 1 1.2 (0.8 - 2.3) 1.2 (0.7 - 2.3) 1.3 (0.9 - 2.4) 2.6 (1.3 - 4.5)
OR: Odds ratio; CI: Confidence interval.
Table 3 - Cardiovascular risk factors based on body mass index.
Body Mass Index (kg/m2)
Risk factor 18.5 - 24.9 25 - 29.9 30 - 34.9 35 - 39.9 > 40 P*
n = 111 n = 181 n = 296 n =2 65 n = 60
Systemic Hypertension (%) 18.9 24.9 45.3 53.6 63.3 .001
DM (%) 4.5 11.1 12.5 17.7 24.4 .001
Hypertriglyceridemia (%) 26.1 32.6 31.8 35.1 40.3 .046
Hypercholesterolemia (%) 54.0 58.6 56.8 51.7 50.3 .29
Glycemia (mg/dL)** 96.6 ± 38.3 103.6 ± 40.4 100.6 ± 29.3 109.6 ± 46.2 113.1 ± 50.7 .001
Triglycerides (mg/dL)** 120.9 ± 78.7 136.1 ± 81.2 145.1 ± 115.8 148.1 ± 148.9 158.8 ± 96.9 .02
Total Cholesterol (mg/dL)** 207.2 ± 41.0 209.3 ± 44.1 210.3 ± 45.9 204.2 ± 42.5 205.2 ± 50.5 .47
HDL-Cholesterol (mg/dL)** 52.6 ± 13.3 48.7 ± 13.7 46.8 ± 12.5 45.5 ± 11.3 45.1 ± 10.1 .001
LDL-Cholesterol (mg/dL)** 131.1 ± 34.3 133.9 ± 39.6 135.6 ± 40.4 129.7 ± 34.6 128.0 ± 41.1 .12
* one-way analysis of variance ** Mean ± standard deviation
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verely obese also reported a significant
risk for developing hypertriglyce-
ridemia.
When the population was divided
into cardiovascular risk categories, ac-
cording to the criteria of Leite et al.,20
as BMI increased so did the percent-
age of patients at high cardiovascular
risk, while low cardiovascular risk de-
creased (Figure 1). Through the logis-
tic regression model, BMI proved to
be significantly correlated to high car-
diovascular risk (P < .001).
DISCUSSION
The present study was undertaken
to examine the prevalence of major
risk factors for atherosclerotic cardio-
vascular diseases associated with obes-
ity level based on BMI. Additionally,
risk factors were aggregated to subdi-
vide the population into high, moder-
ate, and low cardiovascular risk.
A clear association was detected
between increased BMI values and
systemic hypertension, which was con-
sistent with previous reports in litera-
ture. Most epidemiological studies
show that obesity is a strong independ-
ent risk factor for systemic hyperten-
sion.21,22 As early as 1987 while study-
ing hypertension precursors in young
adults, Framingham researchers dem-
onstrated that 78% of systemic hyper-
tension cases in males and 65% of hy-
pertension cases in females could be a
direct result of obesity23. In Brazil, Gus
et al. 14 have demonstrated that BMI
was the anthropometric measurement
that presented the most consistent as-
sociation with systemic hypertension,
both in males and females. Carneiro et
al.13 demonstrated that body fat distri-
bution is also a very important deter-
minant of arterial hypertension.
Other studies in the literature have
demonstrated that the relative risk of
developing type 2 DM increases
exponentially with increased BMI24,25.
Recent publications include data from
over 84,000 women who participated
in the Nurses’ Health Study, demon-
strating obesity to be a major risk for
the onset of diabetes. Women who re-
ported BMI over 35 kg/m2 were shown
to be 39 times more likely to devel-
oping diabetes compared with those
who were normal weight24. In our
population, individuals who were
moderately obese (BMI between 35
and 39.9 kg/m2) and severely obese
(BMI ≥ 40 kg/m2) were respectively at
5.8 and 9.2 times higher risk of devel-
oping DM compared with those who
reported normal BMI.
As for plasma lipids, the present
study revealed that higher levels of
triglycerides and reduced HDL-choles-
terol levels were associated with obes-
ity. However, the study did not reveal
any association between elevated lev-
els of total cholesterol or LDL-choles-
terol and obesity. Those data are con-
sistent with reported findings that the
major dyslipidemia associated with
obesity is a mild to moderate increase
in triglycerides and a decrease HDL-
cholesterol.26,27 Such alterations are
usually associated with small, dense
LDL particles that are more athero-
genic since they have lower affinity
with LDL receptors, closer binding to
arterial wall proteoglycans, and higher
susceptibility to oxidation.28 Previous
studies have demonstrated that an in-
creased BMI is associated with reduc-
tion in LDL particle size.27,29 Therefore,
although no increase in LDL-choles-
terol level was found in association
with obesity in the population under
study, small, dense LDL particles may
have increased, since obesity was
shown to be associated with higher
triglyceride levels and lower HDL-
cholesterol levels.
In addition to examining each of
the major risk factors individually
against BMI, assessment of the sever-
ity level of cardiovascular risks by ag-
gregating all those factors and subdi-
viding the population into high, mod-
erate, and low cardiovascular risk cat-
egories was attempted. To reach such
categorization, criteria as suggested by
Leite et al.20 were used. The population
under study showed BMI and high car-
diovascular risk to be significantly as-
sociated. The data are compatible with
findings reported in the literature of
higher myocardium infarction risk and
cardiovascular mortality in obese in-
dividuals.3,4,9
In the present study we analyzed
just the major risk factors for coronary
heart disease, i.e., blood pressure, to-
tal cholesterol, triglycerides, and dia-
betes. However, part of the relationship
between obesity and cardiovascular
risk could be mediated by newly iden-
tified risk factors. One of these is in-
sulin resistance and its companion,
Figure 1 - Cardiovascular risk categories and body mass index . Chi-square test P < .001.
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hyperinsulinemia. Several hypotheses
have been proposed for a causative
link between insulin resistance (or
hyperinsulinemia) and cardiovascular
risk.30,31 Second, obese individuals typi-
cally carry a proinflammatory state
that may predispose them to acute coro-
nary syndromes. This state is charac-
terized by elevations of serum high-
sensitivity C-reactive protein (hs-
CRP); in fact, increased levels of hs-
CRP reflect high cytokine levels that
may render otherwise stable atheroscle-
rotic plaques vulnerable to plaque rup-
ture32. Previous studies have demon-
strated that obesity is associated with
elevations of hs-CPR33,34. An excess of
adipose tissue apparently secretes in-
creased amounts of several cytokines
that underlie the proinflammatory
state.34,35 Other studies are necessary to
investigate these emerging risk factors
in a Brazilian population.
We conclude that BMI assessment
in a Brazilian population has demon-
strated that increasing levels of obes-
ity are associated with a higher preva-
lence of systemic hypertension, DM,
and hypertriglyceridemia, as well as
reduced HDL-cholesterol levels. These
results are consistent with those re-
ported in the literature and, taken to-
gether, are proof that obesity is clearly
associated with a profile of unfavorable
risks for cardiovascular disease, thus
emphasizing the importance of pre-
vention and treatment of obesity.
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RESUMO
CERCATO C e col. Hipertensão arte-
rial, diabetes melito e dislipidemia
de acordo com o índice de massa
corpórea: estudo em uma popula-
ção Brasileira. Rev. Hosp. Clín.
Fac. Med. S. Paulo 59(3): 113-118,
2004.
OBJETIVO: Determinar preva-
lência de hipertensão arterial, diabete
melito, hipercolesterolemia e hiper-
trigliceridemia em uma população bra-
sileira de acordo com grau de obesi-
dade.
MÉTODO: Estudo retrospectivo
em 1213 adultos (média de idade: 45,2
± 12,8 anos; 80,6 % sexo feminino)
em grupos de acordo com índice de
massa corpórea (normal:18,5-24,4 Kg/
m2; sobrepeso 25-29,9 Kg/m2; obesi-
dade classe1: 30-34,9 Kg/m2; classe 2:
35-39,9 Kg/m2 ; classe 3:³ 40 Kgm2).
Analisamos presença de hipertensão
arterial, diabete melito, hipercoles-
terolemia e hipertrigliceridemia em
cada grupo. Determinamos severidade
do risco cardiovascular, considerando
risco alto pacientes com 2 ou mais dos
seguintes fatores: hipertensão arterial,
HDL ≤ 35mg/dl, colesterol total
≥240mg/dl, triglicérides ≥200mg/dl
quando HDL ≤ 35mg/dl e glicemia
≥126mg/dl; risco moderado aqueles
com 2 ou mais dos seguintes fatores:
hipertensão arterial, HDL ≤ 45,
triglicérides ≥200mg/dl e colesterol to-
tal ≥200mg/dl.
RESULTADOS: Houve aumento
significativo da prevalência de hiper-
tensão arterial, diabete melito,
hipertrigliceridemia, HDL-colesterol
baixo, porém não houve maior
prevalência de hipercolesterolemia. O
odds ratio, ajustado para idade e sexo,
para obesidade em relação aos indiví-
duos de peso normal foi 5,9, 8,6 e 14,8
para hipertensão; 3,8, 5,8 e 9,2 para
diabete melito e 1,2, 1,3 e 2,6 para
hipertrigliceridemia. Após estabelecer
severidade do risco cardiovascular, ve-
rificamos que o índice de massa cor-
pórea se correlacionou de forma signi-
ficativa com alto risco cardiovascular
(p< 0.0001).
CONCLUSÃO: Em nossa popula-
ção, observamos aumento do risco
cardiovascular com aumento do índi-
ce de massa corpórea.
UNITERMOS: Fatores de risco
cardiovascular. Obesidade. Índice de
massa corpórea. Diabetes melito. Hi-
pertensão arterial sistêmica.
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